-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
LAVA Therapeutics NV quarterly/annual Earnings Per Share, Diluted history and growth rate from 2023 to 2024.
- LAVA Therapeutics NV Earnings Per Share, Diluted for the quarter ending June 30, 2025 was -0.32 USD/shares, a 3.23% decline year-over-year.
- LAVA Therapeutics NV annual Earnings Per Share, Diluted for 2024 was -0.94 USD/shares, a 40.1% increase from 2023.
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)